The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Japanese ophthalmology company Santen Pharmaceutical (TYO: 4536) announced that it will launch Ryjusea Mini solution 0.025% ...

Advancements in medical imaging and computational methodologies have significantly transformed the field of ophthalmology, allowing for unmatched precision ...

The Florida Society of Ophthalmology is pushing back against a bill in the Florida House of Representatives that would expand the scope of practice for optometrists, according to a March 19 report ...

Eyenovia (EYEN) stock falls as the company plans a reverse merger with Betaliq, to create an ophthalmology focused drugmaker. Read more here.

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

Dr. Harry Marshak’s innovative approach to blepharoplasty, or eyelid surgery, blends aesthetics and precision for lasting results.

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology ...

Intra-arterial chemotherapy for retinoblastoma can be highly successful in both treatment-naïve and non-naïve eyes.

The bill, sponsored by Rep. Alex Rizo ( HB 449 ), would allow optometrists to “perform board-approved laser and non-laser ophthalmic procedures” and hold themselves out as “optometrists certified in ...